Introduction: Maanshan Fengyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "Maanshan Pharmaceutical") is a wholly-owned subsidiary of Fengyuan Pharmaceutical Co., Ltd., which was established on the basis of the original "Maanshan Pharmaceutical Factory of Anhui Fengyuan Pharmaceutical Co., Ltd." in June 2008. There are more than 300 employees, and professional and technical personnel account for more than 36%. Seven production lines have passed the national GMP certification, and the product forms are freeze-dried powder injection (containing hormones), small-volume injection (including non-sterilization) and raw materials (fermentation, synthesis and extraction). Ma 'anshan Pharmaceutical Co., Ltd. has three new national drugs for injection: ipratropium acetate, ibuprofen fumarate injection, gonadorelin for injection, coenzyme A for injection, hepatocyte growth-promoting factor for injection, adenosine triphosphate coenzyme insulin for injection, omeprazole sodium for injection, pantoprazole sodium for injection, fat-soluble vitamin (I) (II) for injection, cytochrome C injection, oxytocin injection and heparin sodium injection.
Legal Representative: Liu Yonghong.
Date of establishment: June 26, 2008
Registered capital: RMB 6,543.8+45.5 million.
Industrial and commercial registration number: 3405000005887 1
Type of enterprise: limited liability company (wholly owned by a legal person invested or controlled by a non-natural person)
Company Address:No. Meishan Road 1503, Maanshan Economic and Technological Development Zone, Anhui Province.